It was in 1975 when scientists from Ayerst (now Pfizer) discovered a novel compound called rapamycin (also known as Sirolimus) in bacteria on Rapa Nui(Easter Island) in Chile. In 1999 rapamycin obtained FDA approval for the prevention of acute reject

The transfer of technology (TT) is essential in turning intellectual property (IP) generated from innovative research into real-world applications that benefit the general public.

Welcome back to VitaDAO’s monthly longevity research newsletter — we hope you enjoyed our maiden issue!

Welcome Vitalians to the inaugural issue of VitaDAO’s Monthly Longevity Research Newsletter!

By focusing anywhere but the US, DeSci can solve the hardest problems with science & medicine.

Humans can instinctively recognize if someone appears older or younger than their age; so then, it should be apparent that many species, including humans, develop age-related changes at different rates.

If you have been following the longevity field for even just a little a while, you have probably heard of NAD+… a lot. So what is NAD+, and why are people excited about it?

We’re excited to introduce the opening project to be funded by VitaDAO — the world’s first decentralized intellectual property collective.